The bottom line Based on the available evidence, the clearest conclusion is the reassuring one: GLP-1 drugs do not appear to raise overall cancer risk
Metformin is FDA-approved for type 2 diabetes and used off-label for weight support
Programs built for durable outcomes share a few structural commitments: Behavioral support is integrated from the start not added at the point of discontinuation as a retention afterthought, but concurrent with or prior to medication initiation
In the SURMOUNT-1 clinical trial, individuals with overweight/obesity without diabetes taking tirzepatide (5 mg, 10 mg, and 15 mg once weekly) lost 16%, 21.4%, and 22.5% of body weight, respectively, after 72 weeks
Visual Format: Mechanism of action diagram Key Labels: GHK-Cu complex, copper ions, fibroblasts, collagen synthesis, extracellular matrix, glycosaminoglycans, inflammation pathways, wound repair Suggested Layout: Place the GHK-Cu complex in the center